Iovance CEO on its progress with a new cancer treatment for solid tumors

Iovance Biotherapeutics has reported progress with its custom cell therapies for solid tumors. Maria Fardis, Iovance Biotherapeutics CEO, joins CNBC's Meg Tirrell to discuss.